Mo1862 - Outcomes of Dose Escalation and Drug Level Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab

Autor:	Michelle L. Izmaylov, Robin Dalal, Lauren Evers, Sara N. Horst, Dawn B. Beaulieu, Kim Annis, Ailish Garrett, Elizabeth A. Scoville, Audrey L. Bennett, Caroline Duley, Dawn W. Adams, David A. Schwartz
Rok vydání:	2018
Předmět:	medicine.medical_specialty Hepatology business.industry Gastroenterology medicine.disease Inflammatory bowel disease Vedolizumab Drug levels Internal medicine medicine Dose escalation In patient business medicine.drug
Zdroj:	Gastroenterology. 154:S-829
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(18)32826-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0d7fa334c03b74c80874978e1b68df7a https://doi.org/10.1016/s0016-5085(18)32826-9 Zobrazit plný text záznamu